NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ICICI Securities Downgrades Multi Commodity Exchange of India to HOLD

In a reversal of their previous stance, ICICI Securities has downgraded Multi Commodity Exchange of India (MCX) to HOLD from Add in their latest research report. This decision comes after Q4FY26, where the research firm had predicted that earnings estimates would lag actual volume growth. However, they now believe that volume growth has moderated due to lower volatility.

The research report highlights that while increased participation is a structural opportunity, current valuations capture the medium-term upside well. For FY27E and FY28E, ICICI Securities estimates that MCX's future and premium average daily turnover (ADTV) will be around INR 706 billion and INR 98 billion, respectively. This is compared to INR 905 billion and INR 106 billion in Q4FY26, and INR 554 billion and INR 92 billion in April 2026.

Forecast PeriodFuture ADTV (INR billion)Premium ADTV (INR billion)
Q4FY26905106
Apr'2655492
FY27E70698
FY28E776112

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

The downgrade to HOLD is based on a 40x multiple on MCX's FY28E core earnings per share (EPS) of INR 75, which excludes investment income, net of taxes, and adds free cash, including investments, stockholder's funds, and regulatory capital. This valuation results in a target price of INR 3,150 for MCX.

Investor Takeaway

Investors should be cautious of the downgrade of MCX to HOLD from Add by ICICI Securities.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.